SCHEDULE 13D Page 1 of 9
SEC POTENTIAL PERSONS WHO ARE TO RESPOND TO THE COLLECTION OF INFORMATION
1746 CONTAINED IN THIS FORM ARE NOT REQUIRED TO RESPOND UNLESS THE FORM
(2-98) DISPLAYS A CURRENTLY VALID OMB CONTROL NUMBER.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13D
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. 2)*
Moore Medical Corp.
(Name of Issuer)
Common Stock, $.01 Par Value
(Title of Class of Securities)
615799103
(CUSIP Number)
David Selangut, Esq. c/o Ellenoff Grossman & Schole LLP
370 Lexington Avenue, New York, NY 10017
(Name, Address and Telephone Number of Person
Authorized to Receive Notices and Communications)
October 20, 2003
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Sections 240.13d-1(e), 240.13d-1(F) or 240.13d-1(g), check
the following box. [ ]
NOTE: Schedules filed in paper format shall include a signed original and five
copies of the schedule, including all exhibits. See Section 240.13d-7 for other
parties to whom copies are to be sent.
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter
disclosures provided in a prior cover page.
The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
SCHEDULE 13D
CUSIP NO. 615799103 PAGE 2 OF 9
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY)
Bruce J. Haber
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
X (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 93,950
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 17,500
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
93,950
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
17,500
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
111,450
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.5%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
SCHEDULE 13D
CUSIP NO. 615799103 PAGE 2 OF 9
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY)
Royce Kanofsky
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
X (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
PF
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 102,100
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING 500
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
102,100
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
500
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
102,600
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
3.2%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
IN
--------------------------------------------------------------------------------
SCHEDULE 13D
CUSIP NO. 615799103 PAGE 2 OF 9
--------------------------------------------------------------------------------
1 NAMES OF REPORTING PERSONS
I.R.S. IDENTIFICATION NOs. OF ABOVE PERSONS (ENTITIES ONLY)
FHS Enterprises LLC
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
X (a) / /
(b) / /
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 SOURCE OF FUNDS (SEE INSTRUCTIONS)
WC
--------------------------------------------------------------------------------
5 CHECK IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT
TO ITEMS 2(d) OR 2(e) / /
--------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
New York
--------------------------------------------------------------------------------
7 SOLE VOTING POWER
NUMBER OF
SHARES 500
BENEFICIALLY -----------------------------------------------------------------
OWNED BY 8 SHARED VOTING POWER
EACH
REPORTING
PERSON -----------------------------------------------------------------
WITH 9 SOLE DISPOSITIVE POWER
500
-----------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
--------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
500
--------------------------------------------------------------------------------
12 CHECK IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES
CERTAIN SHARES (SEE INSTRUCTIONS) / /
--------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.02%
--------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON (See Instructions)
CO
--------------------------------------------------------------------------------
Item 1 Security and Issuer
1) Common Stock, $0.01 par value (the "Shares") Moore Medical
Corp. (the "Issuer")
P.O. Box 1500
389 John Downey Drive
New Britain, CT 06050
Item 2 Identity and Background
Item 2 is hereby amended and replaced with the following Item 2.
1. a) Bruce J. Haber
b) 65 The Oaks
Roslyn, NY 11576
c) President of BJH Management, LLC
d-e) There has been no convictions, proceedings or securities
violations in the past 5 years.
f) U.S. Citizen
2. a) Royce Kanofsky
b) 1665 Warwick Road
Hewlett, NY 11557
c) Investment Banking
d-e) There has been no convictions, proceedings or securities
violations in the past 5 years.
f) U.S. Citizen
3. a) FHS Enterprises LLC ("FHS")
b) 145 Huguenot Street, Suite 402
New Rochelle, NY 10801
Mr. Haber and Mr. Kanofsky are both members of FHS.
c) FHS Enterprises LLC was organized to acquire and hold
securities.
d-e) N/A
f) FHS Enterprises LLC is a New York Limited Liability Company
organized on February 21, 2001
The aforementioned parties together will be referred to as the
"Reporting Parties."
Item 3 Source and Amount of Funds or Other Consideration
Item 3 is hereby amended and replaced with the following Item 3:
1. The shares of common stock were purchased with personal funds
of the Reporting Parties.
Item 5 Interest in Securities of the Issuer
Item 5 is hereby amended and replaced with the following Item 5:
1. Bruce J. Haber
a-b) Mr. Bruce J. Haber may be deemed to beneficially own
111,450 shares of the Common Stock, which constitutes
approximately 3.5% of the outstanding shares of
Common Stock (based on the 3,189,784 shares of Common
Stock outstanding as of July 26, 2003 as reported on
the June 28, 2003 Quarterly Report on Form 10-Q.
Of these shares:
i) 93,950 shares of Common Stock are owned
directly by Mr. Haber.
ii) 12,000 shares are owned by his wife, Mr.
Haber disclaims beneficial ownership of the
shares held by his wife.
iii) 5,000 shares are owned in a trust in favor
of his daughter in which Mrs. Haber is the
trustee.
iv) 500 shares are attributed to Mr. Haber by
virtue of his part ownership of FHS.
c) Mr. Bruce J. Haber purchased 6,600 shares in the past
60 days at prices between $5.75 and $6.20 per share.
Mr. Haber, Mr. Kanofsky and FHS, as a group beneficially own
approximately 6.7% of the Company's shares of Common Stock.
2. Royce Kanofsky
a-b) Mr. Royce Kanofsky beneficially owns 102,600 shares
of the Common Stock, which constitutes approximately
3.2% of the outstanding shares of Common Stock. Of
these shares, 102,100 are owned directly by Mr.
Kanofsky and 500 shares are attributed to him by
virtue of his part ownership of FHS.
c) Mr. Royce Kanofsky purchased 8,500 shares within the
past 60 days at prices between $5.75 and $6.20 per
share.
Mr. Haber, Mr. Kanofsky and FHS, as a group beneficially own 6.7% of
the Company's shares of Common Stock.
3. FHS
a-b) FHS beneficially owns 500 shares of the Common Stock,
which constitutes approximately 0.02% of the
outstanding shares of Common Stock.
Exhibit A - Agreement: Joint Filing of Schedule 13D
After reasonable inquiry and to the best of our knowledge and belief,
we certify that the information set forth in this statement is true, complete
and correct.
Date: October 20, 2003
FHS Enterprises LLC
By: /s/ Bruce J. Haber
------------------
Bruce J. Haber
President
/s/ Bruce J. Haber
------------------
Bruce J. Haber
/s/ Royce Kanofsky
------------------
Royce Kanofsky
EXHIBIT A
AGREEMENT
JOINT FILING OF SCHEDULE 13D
The undersigned hereby agree to jointly prepare and file with the regulatory
authorities a Schedule 13D and any future amendments thereto reporting each or
the undersign's ownership of securities of Moore Medical Corporation, and hereby
affirm that such Schedule 13D is being filled on behalf of each of them.
FHS Enterprises LLC
Date: October 20, 2003 By: /s/ Bruce J. Haber
New York, NY Bruce J. Haber
President
Date: October 20, 2003 /s/ Bruce J. Haber
New York, NY Bruce J. Haber
Date: October 20, 2003 /s/ Royce Kanofsky
New York, NY Royce Kanofsky